Table:
begin	end	state
1	19	cytoplasmic
20	37	transmembrane
38	43	non-cytoplasmic
44	66	transmembrane
67	94	cytoplasmic
95	120	transmembrane
121	126	non-cytoplasmic
127	146	transmembrane
147	155	cytoplasmic
156	179	transmembrane
180	202	non-cytoplasmic
203	224	transmembrane
225	243	cytoplasmic
244	266	transmembrane
267	277	non-cytoplasmic
278	299	transmembrane
300	334	cytoplasmic
335	357	transmembrane
358	362	non-cytoplasmic
363	388	transmembrane
389	407	cytoplasmic
408	428	transmembrane
429	433	non-cytoplasmic
434	451	transmembrane
452	465	cytoplasmic

Input:
>WP_015448129.1 NCBI__GCF_000230695.2:WP_015448129.1
MTASLEHPEHLRRSLSNRHLQLIAIGGAIGTGLFMGSGKTISLAGPSILLVYLIIGVMLF
FVMRAMGELLLSNLEYKSFIDFSTDLLGPWAGFFCGWTYWFCWVITAIADVIAIAAYAQF
WFPGLAPWIPAVLCVLLLLSLNLVTVKLFGELEFWFALIKIVAIVALIATGFALVAWGFT
SPSGHKASLANLWSDGGFFPKGLSGFFAGFQIAVFAFVGIELVGTTAAETADPKRNLPKA
INSIPVRIIIFYVLALIAIMVVTPWRLVEAGKSPFVELFVLAGIPAAASLINFVVLTSAT
SSANSGIFSTSRMLYGLAEEQHAPKTFARLSRAAVPSLGLLFSCFCLLLGAAMIYLIPDL
ITAFTLITTLSAVLFMFVWSLILFGYIAYRRQRPQLHQASIYKMPGGVFMCWACLAFFVF
VLVLLSLQPDTREALIASPVWFVLLGIGYLWKGRRARRGVALPAE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server